0

Journal Articles

in Percutaneous Coronary Intervention
 1-20 of 80 Articles
Medical News and Perspectives |  May 01, 2013
Study Ignites Debate on New Anticoagulant
Mike Mitka, MSJ
JAMA. 2013;309(17):1763-1764. doi:10.1001/jama.2013.3857.
Original Contribution |  March 13, 2013
Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention
Adnan K. Chhatriwalla, MD; Amit P. Amin, MD; Kevin F. Kennedy, MS; et al.
JAMA. 2013;309(10):1022-1029. doi:10.1001/jama.2013.1556.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  January 02, 2013
CABG Again Outshines Stenting for Some Patients With Coronary Artery Blockage
Mike Mitka, MSJ
JAMA. 2013;309(1):17-18. doi:10.1001/jama.2012.97092.
Review |  December 19, 2012 FREE
Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention:  A Systematic Review and Meta-analysis
Anne Bellemain-Appaix, MD; Stephen A. O’Connor, MD; Johanne Silvain, MD, PhD; et al.
JAMA. 2012;308(23):2507-2516. doi:10.1001/jama.2012.50788.
INCLUDES: CME , Supplemental Content
Preliminary Communication |  December 12, 2012 FREE
Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction:  The TIME Randomized Trial
Jay H. Traverse, MD; Timothy D. Henry, MD; Carl J. Pepine, MD; et al.
JAMA. 2012;308(22):2380-2389. doi:10.1001/jama.2012.28726.
Editorial |  November 07, 2012 FREE
Measured Drug Effect and Cardiovascular Outcomes in Patients Receiving Platelet P2Y12 Receptor Antagonists:  Clarifying the Time and Place for Intensive Inhibition
Matthew J. Price, MD
JAMA. 2012;308(17):1806-1808. doi:10.1001/jama.2012.34011.
Editorial |  October 10, 2012
Public Reporting of PCI Outcomes and Quality of Care:  One Step Forward and New Questions Raised
Mauro Moscucci, MD, MBA
JAMA. 2012;308(14):1478-1479. doi:10.1001/jama.2012.13389.
Original Contribution |  October 10, 2012 FREE
Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction
Karen E. Joynt, MD, MPH; Daniel M. Blumenthal, MD, MBA; E. John Orav, PhD; et al.
JAMA. 2012;308(14):1460-1468. doi:10.1001/jama.2012.12922.
INCLUDES: , Supplemental Content
Editorial |  December 14, 2011
The Trials and Tribulations of Percutaneous Coronary Intervention in Hospitals Without On-site CABG Surgery
Scott Kinlay, MBBS, PhD
JAMA. 2011;306(22):2507-2509. doi:10.1001/jama.2011.1824.
Review |  December 14, 2011 FREE
Percutaneous Coronary Intervention at Centers With and Without On-site Surgery:  A Meta-analysis
Mandeep Singh, MD, MPH; David R. Holmes, MD; Gregory J. Dehmer, MD; et al.
JAMA. 2011;306(22):2487-2494. doi:10.1001/jama.2011.1790.
INCLUDES: , Supplemental Content
Original Contribution |  October 05, 2011 FREE
Prevalence and Outcomes of Same-Day Discharge After Elective Percutaneous Coronary Intervention Among Older Patients
Sunil V. Rao, MD; Lisa A. Kaltenbach, MS; William S. Weintraub, MD; et al.
JAMA. 2011;306(13):1461-1467. doi:10.1001/jama.2011.1409.
INCLUDES: , Supplemental Content
Editorial |  September 28, 2011
Need for Critical Reappraisal of Intra-aortic Balloon Counterpulsation
Gjin Ndrepepa, MD; Adnan Kastrati, MD
JAMA. 2011;306(12):1376-1377. doi:10.1001/jama.2011.1288.
Original Contribution |  September 28, 2011 FREE
Intra-aortic Balloon Counterpulsation and Infarct Size in Patients With Acute Anterior Myocardial Infarction Without Shock:  The CRISP AMI Randomized Trial
Manesh R. Patel, MD; Richard W. Smalling, MD, PhD; Holger Thiele, MD; et al.
JAMA. 2011;306(12):1329-1337. doi:10.1001/jama.2011.1280.
INCLUDES: , Supplemental Content
Original Contribution |  July 06, 2011 FREE
Appropriateness of Percutaneous Coronary Intervention
Paul S. Chan, MD, MSc; Manesh R. Patel, MD; Lloyd W. Klein, MD; et al.
JAMA. 2011;306(1):53-61. doi:10.1001/jama.2011.916.
INCLUDES: , Supplemental Content
Original Contribution |  June 22, 2011 FREE
Association of Door-In to Door-Out Time With Reperfusion Delays and Outcomes Among Patients Transferred for Primary Percutaneous Coronary Intervention
Tracy Y. Wang, MD, MHS, MSc; Brahmajee K. Nallamothu, MD, MPH; Harlan M. Krumholz, MD, SM; et al.
JAMA. 2011;305(24):2540-2547. doi:10.1001/jama.2011.862.
Medical News & Perspectives |  May 25, 2011
Researchers Praise Drug-Eluting Stents but Appropriate Use Is Still Debated
Mike Mitka
JAMA. 2011;305(20):2052-2053. doi:10.1001/jama.2011.684.
Editorial |  May 11, 2011
Evaluation of Agents to Reduce Infarct Size:  It Can Be Quite REVEALing
Deepak L. Bhatt, MD, MPH
JAMA. 2011;305(18):1908-1909. doi:10.1001/jama.2011.600.
Original Contribution |  May 11, 2011 FREE
Patterns and Intensity of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention
William B. Borden, MD; Rita F. Redberg, MD, MSc; Alvin I. Mushlin, MD, ScM; et al.
JAMA. 2011;305(18):1882-1889. doi:10.1001/jama.2011.601.
INCLUDES: , Supplemental Content
Original Contribution |  May 04, 2011 FREE
Coronary Revascularization Trends in the United States, 2001-2008
Andrew J. Epstein, PhD; Daniel Polsky, PhD; Feifei Yang, MS; et al.
JAMA. 2011;305(17):1769-1776. doi:10.1001/jama.2011.551.
INCLUDES: , Supplemental Content
Original Contribution |  March 16, 2011 FREE
Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention:  The GRAVITAS Randomized Trial
Matthew J. Price, MD; Peter B. Berger, MD; Paul S. Teirstein, MD; et al.
JAMA. 2011;305(11):1097-1105. doi:10.1001/jama.2011.290.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  Oct 2012
Initial Experience With Hyperthermic Intraperitoneal Chemotherapy
Olivier Turrini, MD; Eric Lambaudie, MD; Marion Faucher, MD; et al.
JAMA Internal Medicine
Invited Commentary  |  Aug 13/27, 2012
How Drug-Eluting Stents Illustrate Our Health System's Flawed Relationship With Technology:  Comment on “Use of Drug-Eluting Stents as a Function of Predicted Benefit”
Peter W. Groeneveld, MD, MS
JAMA Internal Medicine
Original Investigation  |  Aug 13/27, 2012
Use of Drug-Eluting Stents as a Function of Predicted Benefit:  Clinical and Economic Implications of Current Practice
Amit P. Amin, MD, MSc; John A. Spertus, MD, MPH; David J. Cohen, MD, MSc; et al.
JAMA Internal Medicine
Editor's Correspondence  |  July 9, 2012
Percutaneous Coronary Intervention for Stable Coronary Artery Disease: The Debate Continues
Elvis A. Peter, MD; Nuri I. Akkus, MD; Jai Varma, MD, FSCAI
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems